Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials

BACKGROUND: Adding docetaxel to androgen deprivation therapy (ADT) improves survival in patients with metastatic, hormone-sensitive prostate cancer, but uncertainty remains about who benefits most. We therefore aimed to obtain up-to-date estimates of the overall effects of docetaxel and to assess wh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Oncol
Main Authors: Vale, Claire L, Fisher, David J, Godolphin, Peter J, Rydzewska, Larysa H, Boher, Jean-Marie, Burdett, Sarah, Chen, Yu-Hui, Clarke, Noel W, Fizazi, Karim, Gravis, Gwenaelle, James, Nicholas D, Liu, Glenn, Matheson, David, Murphy, Laura, Oldroyd, Robert E, Parmar, Mahesh K B, Rogozinska, Ewelina, Sfumato, Patrick, Sweeney, Christopher J, Sydes, Matthew R, Tombal, Bertrand, White, Ian R, Tierney, Jayne F
Formato: Artigo
Idioma:Inglês
Publicado em: 2023
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616350/
https://ncbi.nlm.nih.gov/pubmed/37414011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(23)00230-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados